Renren Inc (NYSE:RENN) grew 11.24% on above-average volume Tuesday after the China Internet Network Information Center, state-affiliated research organization, published its latest Statistical Report on Internet Development in China. The report disclosed the number of Internet users in China totaled 618 million and the Internet penetration rate now stands at 45.8%. Amazingly, the world’s most populous nation ended 2013 with the number of mobile Internet users at 500 million. Renren Inc (NYSE:RENN) stock opened at $3.62 in last session, and closed at $3.90, while the day range of RENN stock is $3.61-$3.90.The stock showed a positive weekly performance of 16.77%.
JinkoSolar Holding Co. Ltd. (NYSE: JKS) reported fourth-quarter and full-year 2013 results before markets opened Monday. For the quarter, the Chinese solar panel maker reported adjusted diluted earnings per American Depositary Share (ADS) of $1.28 on revenue of $361.4 million. JinkoSolar Holding Co., Ltd. (NYSE:JKS) stock opened at $32.28, in last session and closed at $35.95, by gained 17.02%.The 52 week range was $3.96-$37.98.Company’s market capitalization is $966.21 million.
Trina Solar Limited (ADR) (NYSE:TSL) will also unveil its fourth-quarter figures bright and early tomorrow. Historically, the company has missed the Street’s bottom-line estimates in five of the past seven quarters, but averages a one-week gain of 1.5% after reporting — though that’s largely due to a jump of 37.2% two quarters ago. Option traders are purchasing TSL calls over puts at a rapid-fire rate, as the security’s 10-day ISE/CBOE/PHLX call/put volume ratio of 14.01 sits just 2 percentage points from a 12-month high. In addition, the stock’s Schaeffer’s put/call open interest ratio (SOIR) of 0.33 ranks below 99% of all other readings of the past year, suggesting short-term options traders have rarely been more call-heavy. Trina Solar Limited (ADR) (NYSE:TSL) stock gained 11.05% and finished the last session at $16.38.The EPS of the stock remained -2.47.Company’s market capitalization is $1.31 billion.
Halozyme Therapeutics, Inc. (NASDAQ:HALO) released its earnings data on Thursday. The company reported ($0.19) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.17) by $0.02, American Banking News.com reports. The company had revenue of $12.50 million for the quarter, compared to the consensus estimate of $21.80 million. During the same quarter in the prior year, the company posted ($0.04) earnings per share. The company’s quarterly revenue was down 42.7% on a year-over-year basis. Halozyme Therapeutics, Inc. (NASDAQ:HALO) stock opened the session at $14.09, and closed the session at $14.97.The 52 week range of the HALO stock remained $5.03-$18.18 and the day range was $14.09-$15.00.
Leave a Reply